Scientists Reverse Brain Aging in Mice by Blocking Protein

Scientists just watched old brains grow young again, and the discovery could change how we think about aging.

Researchers at UC San Francisco found that a single protein called FTL1 appears to be a major driver of brain aging. When levels of this protein rise in the hippocampus (the brain's memory center), connections between brain cells weaken and memory fades.

The team studied mice of different ages, tracking thousands of genes and proteins over time. Only FTL1 stood out as consistently different between young and old animals.

Older mice naturally had higher FTL1 levels. They also had fewer neural connections and struggled with cognitive tests compared to younger mice.

To test whether FTL1 actually causes these problems, researchers artificially increased the protein in young mice. The results were dramatic: their brains started looking and acting old, developing the simplified neural structures and memory problems typically seen in aging.

Then came the breakthrough. When scientists reduced FTL1 in older mice, the animals didn't just stop declining. They got better.

Brain connections that had been lost began rebuilding themselves. Memory test scores improved. The damage appeared to reverse.

"It is truly a reversal of impairments," said Saul Villeda, associate director of the UCSF Bakar Aging Research Institute. "It's much more than merely delaying or preventing symptoms."

The research also revealed that FTL1 affects how brain cells produce energy. Higher levels slow down cellular metabolism, which may explain some of the cognitive decline.

When researchers treated older brain cells with compounds that boost metabolism, they prevented FTL1's negative effects entirely.

Why This Inspires

This discovery offers something rare in aging research: not just prevention, but actual reversal. The brain's ability to rebuild lost connections later in life suggests our neural decline isn't permanent or inevitable.

The findings open doors to potential treatments targeting FTL1 directly or boosting brain metabolism to counter its effects. While human trials are still years away, the research provides a clear target and proof that age-related brain damage can be undone.

"We're seeing more opportunities to alleviate the worst consequences of old age," Villeda said. "It's a hopeful time to be working on the biology of aging."

The study appears in Nature Aging and was funded by the National Institutes of Health, Simons Foundation, and Bakar Family Foundation.

Your brain might have more comeback potential than anyone thought.